Hans‐Peter Gerber
Impact in
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 49
- HER2/EGFR in Cancer Research 20
- CAR-T cell therapy research 14
- Cancer Cells and Metastasis 6
-
- Monoclonal and Polyclonal Antibodies Research 29
- Co-authors
- Napoleone Ferrara (34 shared papers)Jennifer E. LeCouter (2 shared papers)Kenneth J. Hillan (3 shared papers)William F. Novotny (1 shared paper)Vishva M. Dixit (1 shared paper)Ajay K. Malik (6 shared papers)Xiao Huan Liang (5 shared papers)Fabrizio Condorelli (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (11 papers)Blood (7 papers)Biochemical Pharmacology (5 papers)Journal of Biological Chemistry (5 papers)mAbs (5 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Hans‐Peter Gerber
94 papers receiving 22.7k citations
Hans‐Peter Gerber's Hit Papers
Peers
Comparison fields: 5 of 155
- Cancer Research 4.3k
- Oncology 6.0k
- Molecular Biology 12.0k
- Immunology and Allergy 738
- Ophthalmology 991
Countries citing papers authored by Hans‐Peter Gerber
This map shows the geographic impact of Hans‐Peter Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Peter Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Peter Gerber more than expected).
Fields of papers citing papers by Hans‐Peter Gerber
This network shows the impact of papers produced by Hans‐Peter Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Peter Gerber. The network helps show where Hans‐Peter Gerber may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans‐Peter Gerber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The biology of VEGF and its receptors Hit paper breakdown → | 2003 | 8098 |
| 2 | Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Hit paper breakdown → | 2004 | 2204 |
| 3 | Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells Hit paper breakdown → | 1998 | 827 |
| 4 | 1999 | 781 | |
| 5 | Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells Hit paper breakdown → | 2007 | 729 |
| 6 | 1997 | 670 | |
| 7 | 2002 | 606 | |
| 8 | 2003 | 565 | |
| 9 | 2005 | 534 | |
| 10 | 1994 | 528 | |
| 11 | 2004 | 475 | |
| 12 | 2006 | 445 | |
| 13 | 2001 | 375 | |
| 14 | 2001 | 329 | |
| 15 | 2002 | 329 | |
| 16 | 2005 | 310 | |
| 17 | 2014 | 275 | |
| 18 | 2004 | 252 | |
| 19 | 2015 | 236 | |
| 20 | 2002 | 217 |
About Hans‐Peter Gerber
Hans‐Peter Gerber is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research, Molecular Biology and Immunology and Allergy, having authored 95 papers that have together received 23.7k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (34 papers), Monoclonal and Polyclonal Antibodies Research (29 papers), HER2/EGFR in Cancer Research (20 papers), Cancer, Hypoxia, and Metabolism (15 papers), CAR-T cell therapy research (14 papers), Cell Adhesion Molecules Research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Cancer Research (4.3k citations), Oncology (6.0k citations), Molecular Biology (12.0k citations), Immunology and Allergy (738 citations) and Ophthalmology (991 citations). Hans‐Peter Gerber has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Napoleone Ferrara, Jennifer E. LeCouter, Kenneth J. Hillan, William F. Novotny, Vishva M. Dixit, Ajay K. Malik, Xiao Huan Liang, Fabrizio Condorelli, Jeanie Park and Joe Kowalski. Their work appears in journals such as Molecular Cancer Therapeutics, Blood, Biochemical Pharmacology, Journal of Biological Chemistry and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.